89bio, Inc.
89bio, Inc.（ETNB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
etnb · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年2月6日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$25.00
Consensus
$17.17
+15.7% upside
Low
$12.00
Median: $14.5 · Last Close: $14.84
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$17.17
15.7% upside
High Target
$25
68.5%
Low Target
$12
-19.1%
Current Price
$14.84
as of today
Based on analyst price targets, the ETNB stock price prediction for the next 12 months ranges from $12 to $25. The consensus ETNB price forecast of $17.17 implies 15.7% upside from the current price of $14.84.
短期股价预测
Ranging算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.83 | ↓ 0.09% |
1-day model range: $14.82–$14.83. Peak: $14.83 (-0.09%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ETNB · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-09-19 | Raymond James | Downgrade ↓ | Outperform→Market Perform |
| 2025-09-19 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-09-19 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2025-08-25 | B of A Securities | Maintains | Buy→Buy |
| 2025-08-08 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-31 | UBS | Maintains | Buy→Buy |
| 2025-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-02 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on 89bio, Inc. (ETNB) stock. Of the recent 89 rating actions, 2 were upgrades and 6 were downgrades. 15 analysts currently cover ETNB.
分析师推荐趋势
ETNB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 90.9% YoY
Revenue Next Year
$4M
↑ 22.4% YoY
EPS This Year
$-2.21
EPS Next Year
$-2.30
↑ 4.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ETNB EPS of $-2.21 for the current fiscal year, based on estimates from 5 analysts. The ETNB revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ETNB 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ETNB 的共识目标价为 $17.17（+15.7% 上行空间），分析师共识为 Buy。
ETNB 的短期预测（明日）为 $14.83（-0.09%）。
89bio, Inc. 在 NASDAQ 上市，代码 ETNB。ETNB 在 2027 年的整体展望偏积极，在覆盖分析师中约 60% 对应 Buy 共识。
常见问题
ETNB 预测 · 8 个问题根据 15 位华尔街分析师，ETNB 的 12 个月平均目标价为 $17.17，最高 $25.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $14.84，隐含约 +15.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.